Patent application number | Description | Published |
20110253232 | Pressure Sensitive Oxygenation Valve Construction, Intermediate Assembly and Method of Using the Same - A multi-layer valve is provided for allowing oxygen to enter a package while maintaining a level of fluid and leak resistance. The multi-layer valve includes a first layer of adhesive that has a top and bottom face with the bottom face being adhered to a release liner. A permeable layer is provided over the first layer of adhesive, a second layer of adhesive that has a top and bottom face. The bottom face of the first adhesive layer is adhered to the permeable layer and the top face of the first adhesive layer is adhered to a cover layer such that the bottom face of the second layer of adhesive is separable from the permeable layer while the top face of the second layer of adhesive maintains adhesion with the cover layer. | 10-20-2011 |
20120067896 | Resealable Laminate For Heat Sealed Packaging - A resealable and disposable package assembly is described. The assembly includes a container and a multilayer cover laminate that are bonded to one another to initially seal the contents of the package. The package can then be easily opened by at least partially separating the cover laminate along a predesignated interface. The package can be reliably and effectively sealed by recontacting the previously separated cover portions to one another. | 03-22-2012 |
20130055682 | Heat Shrink Packaging System and Method - A packaging system including a heat shrinkable flexible wall container and a heat shrinkable label is described. The label can be applied to the container prior to heat shrinking. Upon subjecting the labeled container containing the items or goods of interest to a heat shrink operation, the label and flexible wall container both undergo shrinking. The shrinkage characteristics of the flexible wall container and the label are matched to one another. Also described are various methods of packaging using the noted systems. | 03-07-2013 |
20130056470 | Tamper Evident Container - A container having provisions that indicate tampering or previous attempts in opening the container is described. The container includes a peel tab for opening the container to thereby gain access to the container interior and contents therein. The container further includes pull tab provisions which must be at least partially separated from a container substrate, in order to gain access to the peel tab. Separation of the pull tab provisions provides indication of tampering or prior opening attempts. Related methods of providing such indication are also described. | 03-07-2013 |
Patent application number | Description | Published |
20100119480 | Methods for treating multiple sclerosis using antisense oligonucleotides - A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient. | 05-13-2010 |
20110312900 | BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE - A method of attenuating a biological effect of cocaine exposure in a primate. Such method includes administering to the primate an amount of a BChE-albumin fusion protein comprising the amino acid substitutions A227S, S315G, A356W, and Y360G, wherein the amount of the fusion protein is effective to cause attenuation of the biological effect of cocaine exposure in the primate. | 12-22-2011 |
20130345293 | METHODS FOR TREATING MULTIPLE SCLEROSIS USING ANTISENSE OLIGONUCLEOTIDES - A method for treating a patient suffering from multiple sclerosis, particularly a relapsing form of multiple sclerosis, comprising periodically administering a pharmaceutical composition comprising a therapeutically effective amount of OLIGONUCLEOTIDE 1 to the patient, thereby treating the patient. | 12-26-2013 |
20140065126 | BChE ALBUMIN FUSIONS FOR THE TREATMENT OF COCAINE ABUSE - A method of attenuating a biological effect of cocaine exposure in a primate. Such method includes administering to the primate an amount of a BChE-albumin fusion protein comprising the amino acid substitutions A227S, S315G, A356W, and Y360G, wherein the amount of the fusion protein is effective to cause attenuation of the biological effect of cocaine exposure in the primate. | 03-06-2014 |
Patent application number | Description | Published |
20130096158 | Treatment Of Multiple Sclerosis With Combination Of Laquinimod And Fingolimod - This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. | 04-18-2013 |
20130324574 | TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMOD - Disclosed is a method for treating an ocular inflammatory disease (OID), e.g., uveitis or conjunctivitis, comprising periodic administration of a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt thereof. Also provided is a pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for use in treating a subject suffering from an OID, uveitis, bacterial conjunctivitis, viral conjunctivitis, an inflammation of the orbital tissue, the lacrimal apparatus, the eyelid, the cornea, the retina or the optic pathway. This application also provides a method for treating a subject suffering from an autoimmune disease-associated ocular inflammation comprising periodic ocular administration to the subject a therapeutically effective amount of laquinimod or a pharmaceutically acceptable salt, and an ocular pharmaceutical composition comprising laquinimod or a pharmaceutically acceptable salt thereof for use in treating an autoimmune disease-associated ocular inflammation. | 12-05-2013 |
20150037263 | TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FINGOLIMOD - This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with fingolimod. This invention also provides a package and a pharmaceutical composition comprising laquinimod and fingolimod for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with fingolimod in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and fingolimod in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. | 02-05-2015 |
Patent application number | Description | Published |
20120317395 | LOW LATENCY REPLICATION TECHNIQUES WITH CONTENT ADDRESSABLE STORAGE - A CAS data storage method and apparatus comprising: receiving input data including a succession of data items with corresponding logical addresses at a source CAS data storage space for storage therein and for replication at a destination CAS data storage space, generating a hash key for each data item at the source storage space, comparing respective hash keys with hash keys stored at a hash key storage table, to determine whether respective further data items are already present at the destination storage device; transferring respective data items to the destination storage space if no match is made to a hash key stored at the hash key storage table, but not transferring respective further data items if a match is made to a hash key stored at the hash key storage table, thereby transferring to the destination storage space only unique data items. | 12-13-2012 |
20130124776 | SECURE DATA STORAGE IN RAID MEMORY DEVICES - A redundant array of independent disk (RAID) memory storage system comprising data storage blocks arranged in a first plurality of data rows and a second plurality of data columns, wherein parity data is stored in additionally defined parity blocks, and wherein numbers of data blocks in respective columns are different, to accommodate the additional diagonal parity data block that the geometry of the system requires. The system is suitable for an SSD array in which sequential disk readout is not required. | 05-16-2013 |
20130173955 | DATA PROTECTION IN A RANDOM ACCESS DISK ARRAY - A disk array memory system comprises: a plurality of disks in a disk array for storage of content data and parity data in stripes, content data in a same stripe sharing parity bits of said parity data, each disk having a spare disk capacity including at least some of a predefined array spare capacity, said array spare capacity providing a dynamic space reserve over said array to permit data recovery following a disk failure event; a cache for caching content data prior to writing to said disk array; and a controller configured to select a stripe currently having a largest spare stripe capacity, for a current write operation of data from said cache, thereby to write all said data of said current write operation on a same stripe, thereby to maximize sharing of parity bits per write operation and minimize separate parity write operations. | 07-04-2013 |
20130305002 | SNAPSHOT MECHANISM - A memory management system for a thinly provisioned memory volume in which a relatively larger virtual address range of virtual address blocks is mapped to a relatively smaller physical memory comprising physical memory blocks via a mapping table containing entries only for addresses of the physical memory blocks containing data. The memory management system comprises a snapshot provision unit to take a given snapshot of the memory volume at a given time, the snapshot comprising a mapping table and memory values of the volume, the mapping table and memory values comprising entries only for addresses of the physical memory containing data. The snapshot is managed on the same thin provisioning basis as the volume itself, and the system is particularly suitable for RAM type memory disks. | 11-14-2013 |